Theravance Biopharma, Inc.
TBPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $37,797 | $39,545 | $298,172 | $89,959 |
| Short-Term Investments | $50,553 | $62,881 | $29,312 | $83,506 |
| Receivables | $68,440 | $17,474 | $16,785 | $57,599 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4,277 | $13,641 | $9,195 | $18,806 |
| Total Curr. Assets | $161,067 | $133,541 | $353,464 | $249,870 |
| Property Plant & Equip (Net) | $35,772 | $45,355 | $52,001 | $53,347 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $68,374 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $157,322 | $203,103 | $201,935 | $3,228 |
| Total NC Assets | $193,094 | $248,458 | $253,936 | $124,949 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $354,161 | $381,999 | $607,400 | $374,819 |
| Liabilities | – | – | – | – |
| Payables | $2,242 | $1,524 | $1,554 | $3,098 |
| Short-Term Debt | $10,712 | $3,923 | $6,753 | $17,443 |
| Tax Payable | $5,853 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $24 | $98 |
| Other Curr. Liab. | $13,278 | $19,320 | $20,384 | $37,948 |
| Total Curr. Liab. | $32,085 | $24,767 | $28,715 | $58,587 |
| LT Debt | $39,108 | $45,236 | $45,407 | $652,075 |
| Deferred Rev, NC | $0 | $0 | $192 | $310 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $240 |
| Other NC Liab. | $107,423 | $99,001 | $91,286 | $2,180 |
| Total NC Liab. | $146,531 | $144,237 | $136,885 | $654,805 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $49,820 | $49,159 | $52,160 | $52,681 |
| Total Liabilities | $178,616 | $169,004 | $165,600 | $713,392 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $1 | $1 |
| Retained Earnings | -$965,522 | -$909,104 | -$853,911 | -$1,726,043 |
| AOCI | $7 | -$65 | -$15 | $0 |
| Other Equity | $1,141,060 | $1,122,164 | $1,295,725 | $1,387,469 |
| Total Equity | $175,545 | $212,995 | $441,800 | -$338,573 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $354,161 | $381,999 | $607,400 | $374,819 |
| Net Debt | $12,023 | $9,614 | -$246,012 | $579,559 |